DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
NUTX logo

Nutex Health Inc. Stock Price

NasdaqCM:NUTX Community·US$1.3b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 50 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

NUTX Share Price Performance

US$200.24
103.05 (106.03%)
​
US$283.00
Fair Value
US$200.24
103.05 (106.03%)
29.2% undervalued intrinsic discount
US$283.00
Fair Value
Price US$200.24
AnalystConsensusTarget US$283.00
AnalystLowTarget US$200.00
AnalystHighTarget US$300.00
Tue, 8 Sep 26
Fair ValueUS$283.00
Share Pricen/a

NUTX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$283 29.2% undervalued intrinsic discount

Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$200 Fairly Valued intrinsic discount

No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$300 33.3% undervalued intrinsic discount

Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
NUTX logo
Nutex Health
20.9% overvalued intrinsic discount

Nutex (NUTX) is undervalued

View narrative
MS
mstock
mstock
Published 19 Nov 2025
Read Narrative
NUTX logo
Nutex Health
29.2% undervalued intrinsic discount
Updated

Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 8 Sep
Read Narrative
NUTX logo
Nutex Health
Fairly Valued intrinsic discount

No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 25 Aug
Read Narrative
NUTX logo
Nutex Health
33.3% undervalued intrinsic discount

Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 3 Sep 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

MS
mstock
NUTX logo

Nutex (NUTX) is undervalued

Fair Value: US$165.64 20.9% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
NUTX logo

NUTX: Arbitration Model And Micro Hospitals Will Drive Future Upside

Fair Value: US$283 29.2% undervalued intrinsic discount
17 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
NUTX logo

NUTX: Arbitration Reset And Capital-Light Expansion Will Shape Future Upside

Fair Value: US$200 Fairly Valued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

3 Risks
4 Rewards
View Full Analysis

Nutex Health Inc. Key Details

US$846.7m

Revenue

US$385.2m

Cost of Revenue

US$461.5m

Gross Profit

US$281.6m

Other Expenses

US$179.9m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
26.27
54.51%
21.25%
7.8%
View Full Analysis

About NUTX

Founded
2011
Employees
1037
CEO
Thomas Vo
WebsiteView website
www.nutexhealth.com

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Recent NUTX News & Updates

User avatar
Narrative Update • Sep 08

NUTX: Arbitration Model And Micro Hospitals Will Drive Future Upside

Nutex Health’s updated analyst price target has moved from $290 to $325, with analysts pointing to the company’s micro-hospital footprint, arbitration-driven model, and capital-light expansion approach as key support for the higher fair value estimate. Analyst Commentary Recent research on Nutex Health focuses on how its micro-hospital network, arbitration-driven revenue model, and capital-light expansion plans feed into the updated valuation views.

Recent updates

No updates

Nutex Health Inc. Competitors

HQY logo

HealthEquity

Symbol: NasdaqGS:HQY
Market cap: US$7.8b
HNGE logo

Hinge Health

Symbol: NYSE:HNGE
Market cap: US$7.1b
PACS logo

PACS Group

Symbol: NYSE:PACS
Market cap: US$7.1b
CHE logo

Chemed

Symbol: NYSE:CHE
Market cap: US$6.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide